Study-year-(ref) N of cases-UVC related | Treatment CR-PR | Other |
---|---|---|
Gharehbagi MM et al.-2011-(8 ) 5 − 4 (%80) UVC related | 0 3 CR/2 Death (3–6 weeks) | Mean GA:30 weeks %80 UVC |
Morag L et al.-2011-(9) 133 − 95(%74) UVC related | 59(%44 ACT) Not stated | Only 70 patients followed median of 55 months (range, 24–96). 14 (20%) normal; 2 (3%) PHT; 18 (26%) LLA; 5 (7%) splenomegaly. |
Korber F et al.-2011-(10) 14 − 1 (%7) UVC related | 2(%16 ACT) 1 CR with ACT, 1 recanalized spontaneous | 14 (6 term; 8 preterm [24–35 weeks]); 13 occlusive, 1 nonocclusive. 11untreated had increased liver arteries. |
Hery G et al.-2013-(11) 3- UVC unrelated | 1(%33 surgical) Not stated | 3 cases GA: a34 weeks ,†37 weeks, ‡39 weeks (all occlusive). None UVC related. iAt 9 years: portal cavernoma, PHTN, splenomegaly † At 9 years: portal cavernoma, PHTN, esophageal varices At 2.5 years: normal portal flow. |
Pergantau H et al.-2014-(12) 7- UVC unrelated | 4(%57ACT) 5CR(4 treated,1 Spontaneous) | At median of 6 years :5 (71%) CR (4 treated; 1 untreated); 1 (14%, untreated) PHTN; 1 (14%, untreated) esophageal varices |
Rios Mendez RE et al.-(13) 1- UVC related | 1(%100 ACT) CR | Follow-up for 2.5 months and reported normal |
Himami F et al.-2014-(14) 1- UVC unrelated | 0 Not stated | At 18 months: portal cavernoma persisted |
Cakir U et al.-2015-(15) 1-UVC related | 1(UFH/LMWH CR for 8 weeks) | 1 term infant. Nonocclusive, post TAPVR surgery. At 6 months: No portal venous thrombosis or PHTN |
Rambaund G et al.-2015-(16) 1- UVC related | 0 CR | 1 case. 34 weeks; nonocclusive; UVC related; associated Tetralogy of Fallot |
Gluffre M et al.-2016-(17) 1- UVC related | 1(LMWH for CR 1 month) | 32 weeks GA appears occlusive but not stated. At 1 year: PR |
Salih CC et al. -2020-(18) 13- (5 complet and 8 partial occlusion) | 13 13 CR (7–120 days (LMWH for 31 ± 13.8 days) | Mean GA: 29 ± 2 weeks No additional data for follow ups. |